The groundbreaking treatment of tirzepatide peptide represents a exciting development in the care of the condition. Distinct from existing drugs, tirzepatide targets two pathways – GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) – leading to improved glucose control and possible reduction in weight. Experts are investigating its po